Figure 2From: S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial Kaplan-Meier curves of progression-free survival (PFS) (A) and post-progression- survival (PPS) (B). Back to article page